Written in Blood
Is a simple test for early detection of melanoma in the eye on its way?
Lauren Robertson | | Quick Read
Early melanoma detection, both of the eye and skin, can dramatically increase the chances of successful treatment. Unfortunately, nevi at the back of the eye are quite common and tend to mimic early signs of the disease. Now, scientists have discovered microRNA biomarkers in the blood that can differentiate between benign nevi and melanoma, as well as identify whether the cancer has metastasized.
“Our research aimed to facilitate the clinical decision process by providing a simple blood test that will enable monitoring of nevi and reduce the need for intense surveillance,” said Mitchell Stark, the lead author of the study from the University of Queensland Dermatology Research Centre, Australia. The test would be used by optometrists, GPs and specialists to monitor biomarker levels in the blood over time and alert them to high-risk patients that may need further tests. The next step is to validate the findings with an independent study and assess the clinical utility of the test.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Ophthalmologist site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.